Collegium Pharmaceutical, Inc. (COLL)
48.88
-0.45
(-0.91%)
USD |
NASDAQ |
Dec 19, 16:00
48.75
-0.13
(-0.27%)
After-Hours: 20:00
Collegium Pharmaceutical Shareholders Equity (Annual): 228.84M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 727.63M |
| Alnylam Pharmaceuticals, Inc. | 67.09M |
| Altimmune, Inc. | 123.51M |
| Vertex Pharmaceuticals, Inc. | 16.41B |
| Viking Therapeutics, Inc. | 880.28M |